Literature DB >> 19446260

Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.

James M Scheiman1.   

Abstract

Choosing NSAID therapy remains confusing and controversial-the challenge for the clinician is to sum all the risks as well as analgesic and anti-inflammatory efficacy. COX-2 inhibitors are an important scientific advance in pain therapy, and using them in a safe and cost-effective manner is possible when all the competing risks are carefully weighed.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19446260     DOI： 10.1016/j.gtc.2009.03.006

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  4 in total

Review 1.  Update on the management of pain in arthritis and the use of cyclooxygenase-2 inhibitors.

Authors:  Edgar Ross
Journal:  Curr Pain Headache Rep       Date:  2009-12

2.  Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain.

Authors:  Joseph V Pergolizzi; Mart van de Laar; Richard Langford; Hans-Ulrich Mellinghoff; Ignacio Morón Merchante; Srinivas Nalamachu; Joanne O'Brien; Serge Perrot; Robert B Raffa
Journal:  J Pain Res       Date:  2012-08-29       Impact factor: 3.133

Review 3.  Piroxicam-β-cyclodextrin: a GI safer piroxicam.

Authors:  C Scarpignato
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 4.  The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage.

Authors:  James M Scheiman
Journal:  Arthritis Res Ther       Date:  2013-07-24       Impact factor: 5.156
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.